Q3 2024 AstraZeneca PLC Earnings Call Transcript
Good morning to those, joining from the US. Good afternoon to those in the UK and Central Europe and good evening to those listening in Asia.
Welcome, ladies and gentlemen, to AstraZeneca's nine months and Q3 Results 2024 webinars for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the Safe Harbor statement.
The Company intends to utilize the Safe Harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.
Although we believe our expectations are based on reasonable assumptions by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.
Any forward looking statements made on this call risk the knowledge and information available at the time of this call. The Company undertakes no obligation to update
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |